2015 Conference Preview
The 2015 Conference Program will feature innovation-focused education sessions that lend expert guidance to emerging industry trends and opportunities. The conference program builds on a fresh education format introduced at InformEx 2014, which drew record-breaking attendance to on-floor sessions. Sessions will include:
Economic Perspectives on the Specialty Chemicals Sector
Featuring: Larry Sloan, President, SOCMA
Learn about the current economic health of the U.S. specialty chemical sector, as well as the broader manufacturing industry representing key markets. Sloan will share enlightening data for specific end-use markets that will help inform decision-making.
Patent Trends: Recent IP Cases and Practices Affecting the Chemical Industry
Featuring: Paul Tully, Partner, McDonnell Boehnen Hulbert & Berghoff LLP
From the recently enacted America Invents Act (AIA) to groundbreaking intellectual property cases at the Federal Circuit and Supreme Court, many recent IP changes will have a profound impact on the chemical industry. This presentation will provide a summary of best practices under the AIA for chemical and pharmaceutical companies, including patent filing strategies and potential patent-challenge tools that are available. Also discussed will be an overview of recent patent cases that have a profound impact on best practices for chemical companies
Carbon: The Final Frontier for Feedstocks
Featuring: Jennifer Holgrem, CEO, LanzaTech
Free, renewable carbon as a feedstock is an increasingly attractive alternative to petrochemical products. And now, it is actually becoming economically viable to convert carbon products into commercial chemicals. Holgrem will dive into the technologies that enable carbon recycling for chemical production, and how fine, specialty and custom
chemical manufacturers can use such processes to their advantage.
Shale Gas: How North America Is Changing the Global Chemical Industry
Featuring: Tom Gellrich, CEO, TopLine Analytics
Shale Gas, a uniquely North American phenomenon, has reduced natural gas prices by two thirds. The chemical industry, which uses natural gas as both a fuel and feedstock, is closely affected, as the resource accounts for as much as 80 percent of finished-product costs. The industry has responded with a $100 billion spending boom, increasing capacity by 50 percent and changing the entire global competitive structure. North America is rapidly becoming the unassailable low cost manufacturing location, as these costs trickle down to fine, specialty and pharmaceuticals. The changes are deeper than lower cost as natural gas, rather than crude oil, becomes the fuel and feedstock of choice. At the same time, many previously available by-product production chemicals are simply no longer available. This has led to significant global shortages such as butadiene which has seen 500 percent price increase in a decade. Find out how significant the changes are, where the impacts will occur in the chemical value chain and what actions leading companies are taking.
News on the TSCA Front: How the Toxic Substances Control Act Affects Business
Featuring: Ghassan Zughaib, ChemADVISOR
In the specialty chemicals sector, It's essential to stay up to date on all the nuances of TSCA, including exemptions that can save you time and money. Learn how the act applies to chemical manufacturers and the different requirements for importers and manufacturers. In this session you'll also gain a better understanding of "new" versus "existing" chemicals, substance restrictions, PreManufacturing Notices (PMN) and noteworthy exemptions.
GHS in 2015: What You Need to Know, and Why You Need to Know It
Featuring: Paula Laux, Senior Regulatory Specialist, The WERCs
Since 2002, when the United Nations adopted GHS (Globally Harmonized System of Classification and Labelling of Chemicals), the chemical industry has sought to streamline and consolidate safety data sheets and labels to better meet these new global requirements. Now that OSHA's newly aligned GHS Hazard Communication Standard requires full adoption by June 1, 2015, it's even more important to understand GHS in a country-specific context. This session outlines general GHS requirements while providing some practical guidance on how to manage country specific differences with major trading partners.
Green Chemistry Panel: Building Sustainability Into Manufacturing
Featuring: The ACS Green Chemistry Institute
New technologies, regulations, consumer and economic forces are driving the growth of green chemistry, a market that's set to expand to nearly $100 billion and save the chemical industry more than $65 billion by 2020. With opportunities abounding, how can companies produce industrially relevant compounds with great efficiency and minimal waste?
Wearable & Textile Electronics: A Booming Market for Chemicals Manufacturers
Featuring: Harry Zervos, Principal Analyst, IDTechEx
Get the latest updates on developments in wearable and textile electronics, with a focus on opportunities for the specialty chemicals industry. With a wide range of wearable tech products — from eyeglasses to footwear to skin patches and even jewelry — the device business is already large, at over $14 billion in 2014. It also has the largest number of big brands involved, including Apple, Adidas, Fujitsu, Nike, Philips, Reebock, Samsung, SAP and Roche behind the most promising new developments. However, truly disruptive new technology, in the form of e-textiles, will also begin to establish major sales in a few years' time and fashion, industrial, commercial and military applications will burgeon as a consequence.
Commercial Panel: Chemical Majors Seeking Bio-Based/Sustainable Feedstocks/Technologies for Renewable & Safer Products
Featuring: Leaders from Infocast, Novamont, SABIC and more
The bio-based space is moving at a rapid pace as consumer trends for greener products drive the market, and the ability to replace petrochemicals with bio alternatives is an extremely valuable attribute. However, the industry is currently facing "growing pains" in moving the industry beyond just vetting technology and into developing renewable applications to fit into the consumer's ultimate value proposition. Therefore, a whole generation of bio-based companies must learn the winning formula for what they need to compete, understand how this industry fits into the larger picture of sustainability and address the challenges associated with carving out a larger competitive industry position to move beyond niche markets.
HPAPI DS/DP Manufacture – Advantages to Streamlining the Manufacturing Process
Featuring: Aaron M Heiss, PhD, Senior Technology Manager/Associate Director - HPAPI at Dr. Reddy's Custom Pharmaceutical Services (CPS)
The pressure on pharmaceutical companies to adapt to changes in the pharma market is ever increasing. Pharmaceutical innovators have to find novel ways of staying ahead of their competition in terms of delivery, quality and cost. One approach to managing the key success factors mentioned above is for pharmaceutical companies to strategically outsource aspects of their drug pipeline. The high potent active pharmaceutical ingredient (HPAPI) industry is a $12B USD industry, with around 10% of the global market (ca $120B) and a 10% growth rate year on year. This growth has fuelled the number of service providers that offer these capabilities to meet the increasing demand. There are very few contract businesses that offer integrated HPAPI drug substance (DS)/drug product (DP) capabilities and even fewer that have a wealth of experience in this area, though the number is growing. Streamlining the manufacturing process by integrating DS/DP production can mitigate risk for the client by reducing timelines and decreasing costs whilst maintaining quality. The HPAPI DS/DP market and the advantages and challenges for pharma companies in outsourcing using an integrated versus non-integrated approach will be discussed. Consideration will be given to the specialist expertise and capabilities that can be gained from manufacturing both the DS and DP, and the potential complexities that CDMOs need to address for successful outcomes.
Biocatalysis: Latest Innovations Fueling the Development of Scalable Enzymes
Featuring: Greg Hughes, Vice President, Alliance Management & Product Development, Codexis
While chemists and engineers have long recognized that it is possible to use natural or ‘wild type' enzymes for industrial applications, it is only in recent years that advances in molecular biology have allowed us to reshape and customize enzymes and other proteins for applications to unnatural substrates and under more strenuous conditions. This presentation will give an overview of techniques that have been used in the past, as well as recent advances in enzyme engineering techniques. The presentation will highlight how these technologies deliver highly active, robust and scalable enzymatic solutions for some of today's more complex chemistry challenges for manufacturers of pharmaceuticals, biotherapeutics, food ingredients and flavorings.
* Speakers and sessions are subject to change